Clinical Trials Browser

Phase 1/2 × Glioma × Antibodies, Monoclonal × Clear all

NCT02855086 2020-03-31

Cetuximab-IRDye 800CW in Detecting Tumors in Patients With Malignant Glioma Undergoing Surgery

Phase 1/2 Terminated

3 enrolled 7 charts

Brain Neoplasms, Glioma